Industry: Pharmaceuticals (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-12-22 | New | $54,999,996 | $54,999,996 | Equity Only | 06b | SEC link |
| 2024-05-13 | New | $50,415,077 | $50,415,077 | Equity Only | 06b | SEC link |
| 2019-10-09 | New | $18,799,907 | $18,799,907 | Equity Only | 06b | SEC link |
| 2017-06-28 | New | $785,687 | $785,687 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| Youssef Bennani | Director |
| Jens Eckstein | Director |
| Lars Ekm | Director |
| Lars Ekman | Director |
| Richard Gaster | Director |
| Justin Gover | Director |
| William Greene | Director |
| Allison J. Hulme | Director, Executive |
| Themasap Khan | Director |
| John Kincaid | Executive |
| David Lowe | Director |
| Ian Massey | Executive |
| James Peyer | Director |
| Matthew J. Plunkett | Executive |
| Michael Powell | Director |
| Nils Regge | Director |
| Davis Ryman | Executive |
| Stelios Tzannis | Director, Executive |
| Ben Zadik | Executive |
| Micah Zajic | Executive |